NIQ GLOBAL INTELLIGENCE PLC ORDINARY SHARES (NIQ)
NIQ lance sa solution Product Intelligence pour dynamiser le commerce basé sur l’IA
NIQ lance sa solution Product Intelligence pour dynamiser le commerce basé sur l’IA
NIQ推出产品智能解决方案,助力AI驱动的商务发展
NIQ推出產品智慧解決方案,賦能AI驅動的商務發展
NIQ führt „Product Intelligence“ ein, um den KI-gesteuerten Handel voranzutreiben
Johnson Controls Announces Quarterly Dividend
Dormant shares – change in the number of shares
Ceased to be an interested party - Harel Insurance Investments and Financial Services Ltd.
Clinical trial NCT07076121: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT05506878 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-09-30 → 2026-04-13 3. primary completion date: 2026-06-30 → 2026-01-13 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06952504: start date: 2025-05-22 → 2025-05-21.